Cargando…

Preclinical efficacy of belinostat in combination with zidovudine in adult T-cell leukemia-lymphoma

Detalles Bibliográficos
Autores principales:	Toomey, Ngoc, Barber, Glen, Ramos, Juan Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577796/ http://dx.doi.org/10.1186/1742-4690-12-S1-P73

Ejemplares similares

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma
por: Ramos, Juan C, et al.
Publicado: (2011)

The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” micro-environment in patients with adult T-cell leukemia lymphoma
por: Kchour, Ghada, et al.
Publicado: (2014)

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes
por: Campuzano-Zuluaga, Germán, et al.
Publicado: (2014)

Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma
por: Hood, Katelyn, et al.
Publicado: (2016)

Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas
por: Allen, Pamela B, et al.
Publicado: (2018)

Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
por: Bodiford, Andrew, et al.
Publicado: (2014)

New developments in the treatment of peripheral T-cell lymphoma – role of Belinostat
por: Reimer, Peter
Publicado: (2015)

The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma
por: Kchour, Ghada, et al.
Publicado: (2013)

Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children
por: Gitta, PK, et al.
Publicado: (2010)

Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
por: Phillips, Adrienne, et al.
Publicado: (2015)

Immunotherapeutic potential of varicella vaccine in smoldering and cutaneous adult T-cell leukemia/lymphoma
por: Amano, M, et al.
Publicado: (2014)

KIR genes and adult T-cell leukemia/lymphoma in patients infected with HTLV-1
por: Melo, Omar, et al.
Publicado: (2015)

Zidovudine.
por: Sperling, R
Publicado: (1998)

Repurposing Belinostat for Alleviation of Atopic Dermatitis
por: Quah, Shan, et al.
Publicado: (2021)

Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1)
por: Merle, Harold, et al.
Publicado: (2015)

Clinical features and outcome of adult T-cell leukemia/lymphoma: University of Miami experience
por: Pimentel, Agustin, et al.
Publicado: (2014)

Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
por: Utsunomiya, Atae, et al.
Publicado: (2015)

Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of HTLV-1
por: Sibon, David, et al.
Publicado: (2015)

Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma
por: Ratner, Lee, et al.
Publicado: (2015)

Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis
por: Shafiee, Arman, et al.
Publicado: (2023)

Sensitive detection and apoptotic cell death induction of adult T-cell leukemia/lymphoma (ATL) cells with photodynamic actions
por: Oka, Takashi, et al.
Publicado: (2014)

Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral t-cell lymphoma
por: Reimer, Peter, et al.
Publicado: (2013)

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma
por: Johnston, Patrick B., et al.
Publicado: (2021)

Immunotherapy using bispecific T cell engager (BiTE(®)) antibodies: preclinical and clinical experience in acute leukemia
por: Subklewe, Marion, et al.
Publicado: (2014)

HTLV-1 proviral load in adult T-cell leukemia/lymphoma (ATLL) patients from non-endemic regions of Argentina
por: Mangano, Andrea, et al.
Publicado: (2014)

Leukemia/lymphoma development in IL-15-deficient TCR-transgenic mice
por: Dubois, Sigrid, et al.
Publicado: (2015)

Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients
por: Pornkuna, Ratiorn, et al.
Publicado: (2014)

Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
por: Yonekura, Kentro, et al.
Publicado: (2015)

Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: retrospective study in Martinique
por: Baubion, Emilie, et al.
Publicado: (2015)

Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α
por: Hodson, Andrew, et al.
Publicado: (2014)

Adult T-cell leukemia/lymphoma following elevation of serum levels of soluble cytokine receptors, sCD25 and sCD30
por: Takemoto, Shigeki, et al.
Publicado: (2014)

Zidovudine-induced myopathy
por: Wiwanitkit, Viroj
Publicado: (2011)

Zidovudine Induced Hyperpigmentation
por: Premjith, Raveendran, et al.
Publicado: (2022)

Preclinical evaluation of MVA-MUC1-IL2 in combination with chemotherapy in murine models
por: De Meyer, Micaël, et al.
Publicado: (2013)

Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models
por: Huseni, Mahrukh, et al.
Publicado: (2014)

Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models
por: Huseni, Mahrukh, et al.
Publicado: (2014)

Immune mediated therapy and MEK inhibition: preclinical assessment of immunobiology and combination activity in vitro and in vivo
por: Stewart, Ross, et al.
Publicado: (2014)

Monitoring the effect of belinostat in solid tumors by H4 acetylation
por: MARQUARD, LENA, et al.
Publicado: (2008)

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer
por: Chan, Daniel, et al.
Publicado: (2013)

Preclinical animal models of COPD
por: Vlahos, Ross
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gra9tei2df54rtpvl5p3u3vpgn